Mankind Pharma Limited (MANKIND) — Announcement

· NSE Neutral
📢 Key Event
Mankind Pharma to attend IIFL investor conference in London
💡 Investor Takeaway
Investors should note the company will engage with analysts in London but no new financial updates are expected from these meetings.

Mankind Pharma announced its participation in IIFL's Invest India Conference and Capital Day 2026 on June 23-24, 2026, with management and officials scheduled for one-on-one and group meetings in London. The filing confirms no unpublished price-sensitive information will be shared during these investor engagements, and the schedule is subject to change. The company also noted the event details will be posted on its official website for investor reference.

📄 View Original Announcement (PDF)

About Mankind Pharma Limited (MANKIND)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,03,330.93 Cr P/E: 49.2

View full MANKIND stock details →

📡 Get AI alerts when MANKIND files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MANKIND — Free

📊 More MANKIND filings

See all MANKIND filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when MANKIND files new disclosures

Track MANKIND filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track MANKIND — Free

Free account · 2 AI queries/day